請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28182
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 鄭尊仁 | |
dc.contributor.author | Yu-Fang Huang | en |
dc.contributor.author | 黃于芳 | zh_TW |
dc.date.accessioned | 2021-06-13T00:02:16Z | - |
dc.date.available | 2008-08-08 | |
dc.date.copyright | 2007-08-08 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-30 | |
dc.identifier.citation | Brown L, Fenning A, Chan V, Loch D, Wilson K, Anderson B, et al. 2002. Echocardiographic assessment of cardiac structure and function in rats. Heart Lung Circ 11(3):167-73
Brooks WW, Bing OH, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH. 1997. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat. Circulation. 96(11): 4002-4010. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, et al. 2004. Expert Panel on Population and Prevention Science of the American Heart Association. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation 109(21):2655-2671. Burnett RT, Dales R, Krewski D, Vincent R, Dann T, Brook JR. 1995. Associations between ambient particulate sulfate and admissions to Ontario hospitals for cardiac and respiratory diseases. Am J Epidemiol 142:15–22. Cammer P, Perschagen G, Ahlborg U, Ljungvist S, Victorin K. 1998. Health effects of diesel exhaust emissions. Stockholm, Nordic Council of Ministers. Chang CC, Hwang JS, Chan CC, Wang PY, Hu TH, Cheng TJ. 2004. Effects of concentrated ambient particles on heart rate, blood pressure, and cardiac contractility in spontaneously hypertensive rats. Inhal Toxicol 16(6-7):421-429. Costa DL, Lehmann JR, Winsett D, Richards J, Ledbetter AD, Dreher KL. 2006. Comparative pulmonary toxicological assessment of oil combustion particles following inhalation or instillation exposure. Toxicol Sci 91: 237-246. de Simone G, Wallerson DC, Volpe M, Devereux RB. 1990. Echocardiographic measurement of left ventricular mass and volume in normotensive and hypertensive rats. Necropsy validation. Am J Hypertens 3(9):688-696. Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, et al. 2006. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. JAMA 295(10):1127-1134. Francis GS, Wilson Tang WH, Sonnenblick EH. 2004. Pathophysiology of heart failure. In: Hurst’s The Heart (Fuster V, Alexander RW, O’Rourke RA). USA: The McGraw-Hill Companies Inc 11 edition, 697-721. Hoek G, Brunekreef B, Fischer P, van Wijnen J. 2001. The association between air pollution and heart failure, arrhythmia, embolism, thrombosis, and other cardiovascular causes of death in a time series study. Epidemiology 12:355-357. Jackson G, Gibbs CR, Davies MK, Lip GY. 2000. ABC of heart failure. Pathophysiology. BMJ 320(7228):167-170. Jessup M, Brozena S. 2003. Heart failure. N Engl J Med 348(20):2007-2018. Koken PJ, Piver WT, Ye F, Elixhauser A, Olsen LM, Portier CJ. 2003. Temperature, air pollution, and hospitalization for cardiovascular diseases among elderly people in Denver. Environ. Health Perspect 111:1312-1317. Lemons JA, McGuire DK, Drazner MH. 2003. B-type natriuretic peptide in cardiovascular disease. Lancet 362(9380):316-322. Li Z, Bing OB, Long X, Robinson KG, Lakatta EG. 1997. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 272:2313–2319. Linn WS, Szlachcic Y, Gong H Jr, Kinney PL, Berhane KT. 2000. Air pollution and daily hospital admissions in metropolitan Los Angeles. Environ Health Perspect 108:427– 434. Litwin SE, Katz SE, Morgan JP, Douglas PS. 1994. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 89(1):345-354. Mann DL. 1999. Mechanisms and models in heart failure: A combinatorial approach. Circulation 100(9):999-1008. Muders F, Elsner D. 2000. Animal models of chronic heart failure. Pharmacol Res 41:605-612. Metzger KB, Tolbert PE, Klein M, Peel JL, Flanders WD, Todd K. 2004. Ambient air pollution and cardiovascular emergency department visits. Epidemiology 15:46-56. Mills NL, Törnqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W. 2005. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation 112(25):3930-3936. Morris RD, Naumova EN. 1998. Carbon monoxide and hospital admissions for congestive heart failure: evidence of an increased effect at low temperatures. Environ Health Perspect 106:649–653. Nemmar A, Al-Maskari S, Ali BH, Al-Amri IS. 2007. Cardiovascular and lung inflammatory effects induced by systemically administered diesel exhaust particles in rats. Am J Physiol Lung Cell Mol Physiol 292(3):L664-L670. Nemmar A, Peter HM, Dinsdale D, Vermylen J, Hoylaerts MF, Nemery B. 2003a. Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation 107: 1202-1208. Nemmar A, Nemery B, Hoet PHM, Vermylen J, Hoylaerts MF. 2003b. Pulmoanry inflammation and thrombogenicity caused by diesel particles in hamster: role of histamine. Am J Respir Crit Care Med 168(11):1366-1372. Peel JL, Metzger KB, Klein M, Flanders WD, Mulholland JA, Tolbert PE. 2007. Ambient air pollution and cardiovascular emergency department visits in potentially sensitive groups. Am J Epidemiol 165(6):625-633. Pope III CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K. 2002. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution, JAMA 287: 1132-1141. Pope III CA, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, et al. 2004. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109:71-77. Rosamond W. Flegal K. Firday G, Furie K, Go A, Greenlund K, et al. 2007. Heart disease and stroke statistics ----2007 update. Circulation 115: e69-e171. Salvi S, Blomberg A, Rudell B, Kelly F, Sandström T, Holgate St. et al. 1999. Acute inflammatory responses in the airways and peripheral blood after short-term exposure to diesel exhaust in healthy human volunteers. Am J Respir Crit Care Med 159(3):702-709. Salvi SS, Nordenhall C, Blomberg A, Rudell B, Pourazar J, Kelly FJ, et al. 2000. Acute exposure to diesel exhaust increases IL-8 and GRO-alpha production in healthy human airways. Am J Respir Crit Care Med 161(2 Pt 1):550-557. Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. 2000. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med 343: 1742-1749. Schwartz J, Morris R. 1995. Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am J Epidemiol 142:23–35. Schwartz J, Dockery DW, Neas LM. 1996. Is daily mortality associated specifically with fine particles? J Air Waste Manag Assoc 46:927–939. Schwartz J. 1997. Air pollution and hospital admissions for cardiovascular disease in Tucson. Epidemiology 8(4):371–377. Schwartz J. 2001. Air pollution and blood markers of cardiovascular risk. Environ Health Perspect 109:405-409. Seaton A, MacNee W, Donaldson K, Godden D.1995. Particulate air pollution and acute health effects. Lancet 345:176–178. Seddon M, Looi YH, Shah AM. 2007. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93(8):903-907. Sioutas C, Delfino RJ, Singh M. 2005. Exposure assessment for atmospheric ultrafine particles (UFPs) and implications in epidemiologic research. Environ Health Perspect 113:947-955. Symons JM, Wang L, Guallar E, Howell E, Dominici F, Schwab M, et al. 2006. A case-crossover study of fine particulate matter air pollution and onset of congestive heart failure symptom exacerbation leading to hospitalization. Am J Epidemiol 164(5):421-433. Verrier RL, Mittleman MA, Stone PH. 2002. Air pollution: an insidious and pervasive component of cardiac risk. Circulation 106:890–892. Wong TW, Lau TS, Yu TS, Neller A, Wong SL, Tam W, et al. 1999. Air pollution and hospital admissions for respiratory and cardiovascular diseases in Hong Kong. Occup Environ Med 56:679–683. Wellenius GA, Bateson TF, Mittleman MA, Schwartz J. 2005. Particulate air pollution and the rate of hospitalization for congestive heart failure among Medicare beneficiaries in Pittsburgh, Pennsylvania. Am J Epidemiol 161:130 –136. Wellenius GA, Schwartz J, Mittleman MA. 2006. Particulate air pollution and hospital admissions for congestive deart failure in seven United States Cities. Am J Cardiol 97:404–408. Yoshino S, Sagai M. 1999. Enhancement of collagen-induced arthritis in mice by diesel exhaust particles. J Pharmacol Exp Ther 290:524–529 Blasig IE, Blasig R, Löwe H. 1984. Myocardial lipid peroxidation during isoproterenol-induced blood flow reduction in rat myocardium. Biomed Biochim Acta 43(8-9): S171-S174. Byon KY, Fleckenstein A. 1969. Parallel influence of isometric tension development and O2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproteranol and organic Ca antagonists (iproveratril, D 600, prenylamine) Pflugers Arch 312(1):R8-9. Chappel CI, Rona G, Balazs T, Gaudry R. 1959. Severe myocardial necrosis produced by isoproterenol in the rat. Arch Int Pharmacodyn Ther 122:123-128 Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. 1997. Vale of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350:1349-1969. Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, et al. 1994. Plasma brain natriuretic peptides in assessment of acute dysponea. Lancet 343: 440-444. Fleckenstein A, Janke J, Döring HJ, Leder O. 1974. Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology. Recent Adv Stud Cardiac Struct Metab.4:563-580. Fleckenstein A, Kanke J, Döring HJ, Leder O. 1975. Key role of Ca in the production of noncoronarogenic myocardial necroses. Recent Adv Stud Cardiac Struct Metab 6:21-32. Francis GS, Wilson Tang WH, Sonnenblick EH. 2004. Pathophysiology of heart failure. In: Hurst’s The Heart (Fuster V, Alexander RW, O’Rourke RA). USA: The McGraw-Hill Companies Inc 11 edition, 697-721. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y,et al. 1995. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92(6):1558-1564. Hodsman GP, Kohzuki M, Howes LG, Sumithran E, Tsunoda K, Johnston CI. 1988. Neurohumoral responses to chronic myocardial infarction in rats. Circulation 78(2):376-381. Ingram GI, Jones RV, Hershgold EJ, Denson KW, Perkins JR. 1977. Factor-VIII activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation. Br J Haematol 35(1):81-100. Jackson G, Gibbs CR, Davies MK, Lip GY. 2000. ABC of heart failure. Pathophysiology. BMJ 320(7228):167-170. Jessup M, Brozena S. 2003. Heart failure. N Engl J Med 348(20):2007-2018. Lee DS, Vasan RS. 2005. Novel markers for heart failure diagnosis and prognosis. Curr Opin Cardiol 20(3):201-210. Muders F, Elsner D. 2000. Animal models of chronic heart failure. Pharmacol Res 41:605-612. Mizuno Y, Yoshimura M, Harada E, Nakayama M, Sakamoto T, Shimasaki Y, et al. 2000. Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 86: 1036–1040. Okuda N, Hayashi T, Mori T, Inamoto S, Okabe M, Mieno S, Horimoto H, Kitaura Y. 2005. Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure. Hypertens Res 28(5):431-438. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, et al. 1979. Myocardial infarct size and ventricular function in rats. Circ Res 44(4):503-512. Pinelli A, Trivulzio S, Tomasoni L, Brenna S, Bonacina E, Accinni R. 2004. Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure. Eur J Pharm Sci 23(3):277-285. Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, et al. 2001. Natriuretic peptides in patients with aortic stenosis. Am Heart J 142: 725–32. Raab W, Vanlith P, Lepeschkin E, Herrlich HC. 1962. Catecholamine-induced myocardial hypoxia in the presence of impaired coronary dilatability independent of external cardiac work. Am J Cardiol 9:455-470. Rathore N, John S, Kale M, Bhatnagar D. 1998. Lipid peroxidation and antioxidant enzymes in isoproterenol induced oxidative stress in rat tissues. Pharmacol Res 38(4):297-303. Remião F, Carmo H, Carvalho FD, Bastos ML. 2000. Inhibition of Glutathione Reductase by Isoproterenol Oxidation Products. J Enzyme Inhib 15(1):47-61. Richards AM, Doughty R, Nicholls MG, et al, for the Australia-New Zealand Heart Failure Group. 1999. Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Circulation 99: 786–92. Rosamond W. Flegal K. Firday G, Furie K, Go A, Greenlund K, et al. 2007. Heart disease and stroke statistics ----2007 update. Circulation 115: e69-e171. Sudoh T, Kangawa K, Minamino N, Matsuo H. 1988. A new natriuretic peptide in porcine brain. Nature 332(6159):78-81. Teerlink JR, Pfeffer JM, Pfeffer MA. 1998. Effect of left ventricular sphericity on the evolution of ventricular dysfunction in rats with diffuse in animal models of myocardial necrosis. J Card Fail 4(1):45-56. Teerlink, JR, Pfeffer J M, Pfeffer MA. 1994. Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 75:105-113. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. 1994. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90: 195-203. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28182 | - |
dc.description.abstract | 柴油引擎微粒對自發性高血壓鼠之心室功能研究
目的:雖然有流行病學研究指出,空氣污染中的微粒和心衰竭的死亡率及急診入院率有關,但結果並不一致。近來有研究指出,罹患心衰竭的病人對於粒徑2.5微克以下的微粒(PM2.5)特別敏感,但作用機轉仍不清楚,所以我們進一步用動物實驗來探討其因果關係。 方法:利用14及16月大的雄性自發性高血壓大鼠作為研究心衰竭之動物模式,以氣管灌注方式,每隔二週分別暴露生理食鹽水(控制組,N=12)及柴油引擎微粒(DEP) 500μg/rat (N=12)共三次。在灌注前後,利用心臟超音波技術測量左心室舒張期(LVDd)和收縮期(LVSd)的內徑,及心室短縮分率(FS)的改變評估左心室功能,並觀察六週內暴露組及控制組的存活率差異。 結果:暴露DEP的大鼠其最後存活率較暴露生理食鹽水之大鼠來的低(50% v.s. 67%),但無統計上差異。在心臟超音波方面,發現暴露DEP後之高血壓大鼠較暴露前有較低的FS(55.7% v.s. 45.45%, p<.05),及較大的LVDd(0.56cm v.s.0.49cm,p=.056)。 結論:結果顯示柴油引擎微粒可能使原本左心室受損之個體其左心室功能更加惡化,這些發現支持流行病學研究之結果。 Isoproterenol 誘發左心室受損大鼠模式建立 目的:流行病學研究已證實空氣中的微粒濃度與心衰竭入院的發生率有正相關,為了探空氣微粒與心衰竭的因果關係,須建立一可行的心室功能受損之疾病動物模式,並評估此模式之心臟功能及受損程度。 方法:利用20隻八週大之雄性Wistar大鼠,連續兩天皮下施打isoproterenol 150mg/kg (實驗組; n=16)及IDD water (對照組; n=4)。於三週後抽取尾部靜脈血,並在六週後以心臟超音波評估左心室舒張期(LVDd)和收縮期(LVSd)的內徑,及心室短縮分率(FS)後進行犧牲,並抽取血液及摘除心臟。後續將利用ELISA來量測血液中第三週和第六週之BNP濃度。並觀察六週內實驗組及控制組的存活率差異。 結果:施打isoproterenol之實驗組24小時死亡率及總死亡率分別為43.75%及50%。心臟超音波部份,實驗組之FS (35.25%)低於控制組的FS (44.59%),並達到統計上的意義 (p=0.0197)。實驗組血液中的BNP濃度,於打藥後由第三週0.359 ng/ml增加到第六週的0.435 ng/ml,亦達到統計上意義 (p=0.0001)。 結論:本研究成功利用八週大雄性Wistar大鼠,連續兩天施打isoproterenol 150mg/kg。於六週後,大鼠有心肌受損及左心室功能下降的情形,為一可行之左心室受損之動物模式。 | zh_TW |
dc.description.abstract | Decreased left ventricular function in spontaneously hypertensive rats exposed to diesel exhaust particles
Objective: Epidemiologic studies have shown that the death and hospital admissions of heart failure are associated with particulate matter, but the association is not consistent. Resent studies reported that patients with heart failure were more sensitive to particulate matter with median aerodynamic diameter <2.5μg/m3 (PM2.5). Here, we conducted an animal study to further investigate the causal relationship between diesel exhaust particles (DEP) exposure and left ventricular function. Method: A total of 24 14- or 16-month-old male spontaneously hypertensive rats (SHR) were exposed intra-tracheally to DEP of 500μg/rat (n=12) and saline as the control (n=12) every 2 weeks for three times. Left ventricular systolic (LVDs) and diastolic (LVDd) diameter and the fraction shortening (FS) were measured before and after treatment using echocardiography. Result: Compared to the control group, DEP exposed SHRs have lower survival rate (50% v.s. 67%), but this did not reach a statistic signification. After DEP exposure, FS in SHR was decreased from 55.7% to 45.5% (p<0.05), and LVDd was increased from 0.49 cm to 0.56cm (p=.056). The change of these values in control group was statistically insignificant. Conclusion: Our results suggest that DEP may impair LV function, which may lead to decompensation in subjects with existing LV impairment. The findings also support previous epidemiology studies. Establishment of a left ventricle-dysfunction animal model induced by isoproterenol Objective: Epidemiologic studies showed that the increasing hospital admissions for heart failure are associated with the concentration of particulate matter in the air. In order to investigate the underlying mechanism, it is needed to establish an appropriate animal model of left ventricular impairment, and further to evaluate the function and the degree of impairment. Method: A total of 20 8-week-old male Wistar rats randomly received 150 mg/kg isoproterenol (ISO group, n=16) or IDD water (control group, n=4) twice for 2 days. Rat was drawn blood from each tail vain at 3 weeks after injection. At 6 weeks after injection, rats were assessed the left ventricular diastolic diameters (LVDd) and fractional shortening (FS) by echocardiography, and sacrificed to get the blood and the heart. The BNP concentration of blood was measured by ELISA. We also observed the difference of mortality between ISO and control groups during experimental period. Result: The immediate (24-hour) and total mortality were 43.75% and 50% in ISO group. In echocardiography, the FS of ISO group (35.25%) was lower than that of control group (44.59%) significantly (p=0.0197). The concentration of blood BNP was increased from 0.359 ng/ml to 0.435 ng/ml (p=0.0001) in the ISO group at 3 to 6 weeks after injection. Conclusion: This study successfully established the left ventricle-dysfunction animal model by using 8-week-old male Wistar rats received 150 mg/kg isoproterenol twice for 2 days, and rats were myocardial impaired and decreased LV function at 6 weeks after injection. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T00:02:16Z (GMT). No. of bitstreams: 1 ntu-96-R94841002-1.pdf: 565997 bytes, checksum: 2e7f137d5bcc9f6cff9cf67010337a2b (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 致謝 i
Table of Content ii Part I - 1 - 摘要 - 2 - Abstract - 3 - 1. Introduction - 4 - 1.1 Research Objectives - 4 - 1.2 Backgrounds - 4 - 1.2.1 Epidemiology of Particulate Matter Induced Heart Failure - 4 - 1.2.2 Diesel Exhaust Particles in Cardiovascular Effects - 5 - 1.2.3 Pathophysiology of Heart failure - 6 - 1.2.4 Animal Model of Heart Failure - 7 - 1.2.5 Echocardiography - 8 - 2. Materials and Methods - 9 - 2.1 Animal Care - 9 - 2.2 Animal Model - 9 - 2.3 Study Design - 9 - 2.4 Observation - 10 - 2.5 Echocardiographical Parameter of Heart Failure - 10 - 2.6 Statistical Analysis - 10 - 3. Results - 11 - 3.1 Observation - 11 - 3.2 Survival Rate - 11 - 3.3 Echocardiography - 11 - 3.3.1 Left Ventricular Dimensions - 12 - 3.3.2 Fractional Shortening - 12 - 4. Discussion - 12 - Reference - 16 - Tables and Figures - 23 - Part II - 31 - 摘要 - 32 - Abstract - 33 - 1. Introduction - 34 - 1.1 Research objectives - 34 - 1.2 Backgrounds - 34 - 1.2.1 Pathophysiology of Heart Failure - 34 - 1.2.2 Animal model of heart failure - 35 - 1.2.3 Echocardiography - 37 - 1.2.4 Biomarkers of Congestive Heart Failure - 37 - 2. Material and Method - 38 - 2.1 Animal Care - 38 - 2.2 Study Design - 38 - 2.3 Observation - 39 - 2.4 Echocardiographical Parameter of Heart Failure - 39 - 2.5 BNP - 39 - 2.5.1 ELISA - 39 - 2.6 Histology - 40 - 2.7 Statistical Analysis - 40 - 3. Result - 40 - 3.1 Mortality - 40 - 3.2 Echocardiography - 41 - 3.3 BNP - 41 - 3.3.1 ELISA - 41 - 3.4 Histology - 41 - 4. Discussion - 41 - Reference 45 Tables and Figures 49 | |
dc.language.iso | en | |
dc.title | 微粒空氣污染物對心臟功能不全大鼠之心血管研究:
1. 柴油引擎微粒對自發性高血壓鼠之心室功能毒性探討 2. Isoproterenol 誘發左心室功能不全大鼠模式建立 | zh_TW |
dc.title | Study on cardiovascular toxicity of ambient particles in rats with left ventricular dysfunction
1. Decreased left ventricular function in spontaneously hypertensive rats exposed to diesel exhaust particles 2. Establishment of a left ventricle-dysfunction animal model induced by isoproterenol | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 陳文鍾,蘇大成,黃建華 | |
dc.subject.keyword | 柴油引擎微粒,自發性高血壓大鼠,心衰竭,心臟超音波,左心室受損,動物模式,isoproterenol, | zh_TW |
dc.subject.keyword | DEP,SHR,heart failure,echocardiography,left ventricular dysfunciton,animal model,isoproterenol, | en |
dc.relation.page | 55 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-07-31 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 職業醫學與工業衛生研究所 | zh_TW |
顯示於系所單位: | 職業醫學與工業衛生研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 552.73 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。